MYCN and neoplasm: However, little is known about how aberrant N-Myc expression cooperates with specific genomic events such as loss of TP53, and RB1 and other molecular alterations to promote the acquisition of the neuroendocrine phenotype and the heterogeneity of tumor evolution towards NEPC from CRPC in the absence of androgen.